Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors
Authors:
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (6) , 811-818
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society
This publication has 35 references indexed in Scilit:
- Properties of L-Type Amino Acid Transporter 1 in Epidermal Ovarian CancerInternational Journal of Gynecological Cancer, 2010
- The rationale for mTOR inhibition in epithelial ovarian cancerExpert Opinion on Investigational Drugs, 2009
- Aminopeptidase inhibition as a targeted treatment strategy in myelomaMolecular Cancer Therapeutics, 2009
- ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cellsAmerican Journal of Physiology-Cell Physiology, 2007
- Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Expression and functional characterization of the system l amino acid transporter in KB human oral epidermoid carcinoma cellsCancer Letters, 2004
- Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity.The Journal of Toxicological Sciences, 2003
- Intracellular Sensing of Amino Acids in Xenopus laevis Oocytes Stimulates p70 S6 Kinase in a Target of Rapamycin-dependent MannerJournal of Biological Chemistry, 2002
- Structure, Function, and Tissue Expression Pattern of Human SN2, a Subtype of the Amino Acid Transport System NBiochemical and Biophysical Research Communications, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976